The U.S. Food and Drug Administration, FDA, has approved a new drug by Danish pharmaceutical company H. Lundbeck A/S and Japanese Otsuka Pharmaceutical Co Ltd. The drug will help treat patients with severe depression and schizophrenia.
Danish researchers have exposed a protein, which can predict the development of asthma.
The growing market for individualized pharmacotherapy, also called personalized medicine, is worth billions on a global level. In Denmark, personalized medicine is considered to have great potential and provides an opportunity to launch a new innovative project offering genetic heritage analyses to 100,000 Danes.
Randers Regional Hospital introduces a new operation method with a 50 pct. higher success rate.
HRH Princess Marie of Denmark enters into collaboration with the Hans Christian Andersen Children’s Hospital at Odense University Hospital to help raise awareness of the hospital’s work with children and adolescents.
The Danish NEXT initiative has applied to establish two new pilot study centers following massive interest from both industry and hospitals.
Danish Lise Kingo has been appointed new Executive Director of the United Nations Global Compact.
A new annual report from Statens Serum Institut concludes that more cancer patients complete their treatment course within the time limits guaranteed to all Danish citizens by the Danish Health and Medicines Authority.
Almost half of Danes over the age of 60 have renewed a prescription online.
Assisted living technologies are increasingly becoming part of the daily municipal service, according to a new report; and the human gains are significant for both citizens and care staff.